Evidence map›Paper›PMID 21613252›Full record

ReviewBlood2011

The multifunctional role of EKLF/KLF1 during erythropoiesis.

Miroslawa Siatecka, James J Bieker

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06433570 (Detection of Krupple Like Factor -1), which is not on this map. Cited by 188 papers.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06433570 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients

TypeobservationalSponsorAssiut UniversityRan2024 to 2027Enrolled100ConditionsEKLF Mutations in Beta Thalassemia PatientsArmsmultiplex PCR
3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 319 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Nutrigenomic profiling identifies ZIP10 (Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Miroslawa SiateckaDepartment of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY, USA.
James J Bieker
Regenerative Medicine Institute · MXStem Cell Institute · PA

Funding

Function of Putative Determinant in HematopoiesisR01DK046865 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI JAMES J BIEKER · 1993 to 2026
$11.2M
Bipotential lineage determination by EKLFR01DK077822 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIEKER, JAMES J · 2008 to 2012
$1.7M
HEMATOPOIETIC STEM CELL COMMITMENT--MOLECULAR REGULATIONR01DK048721 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BIEKER, JAMES J · 1996 to 2004
$1.0M
NIDDK NIH HHS DK46865NIDDK NIH HHS DK48721NIDDK NIH HHS DK77822NIDDK NIH HHS R01 DK046865NIDDK NIH HHS R01 DK048721NIDDK NIH HHS R01 DK077822
6 · The paper itself

Abstract

The cellular events that lead to terminal erythroid differentiation rely on the controlled interplay of extra- and intracellular regulatory factors. Their downstream effects are highly coordinated and result in the structural/morphologic and metabolic changes that uniquely characterize a maturing red blood cell. Erythroid Krüppel-like factor (EKLF/KLF1) is one of a very small number of intrinsic transcription factors that play a major role in regulating these events. This review covers 3 major aspects of erythropoiesis in which EKLF plays crucial functions: (1) at the megakaryocyte-erythroid progenitor stage, where it is involved in erythroid lineage commitment; (2) during the global expansion of erythroid gene expression in primitive and definitive lineages, where it plays a direct role in globin switching; and (3) during the terminal maturation of red cells, where it helps control exit from the cell cycle. We conclude by describing recent studies of mammalian EKLF/KLF1 mutations that lead to altered red cell phenotypes and disease.

Indexed as

AnimalsCell CycleCell LineageErythroid Precursor CellsErythropoiesisGene Expression Regulation, DevelopmentalGene Regulatory NetworksGenes, SwitchGlobinsHaploinsufficiencyHematologic DiseasesHumansKruppel-Like Transcription FactorsMiceModels, BiologicalMutationerythroid Kruppel-like factorGlobinsKruppel-Like Transcription Factors

Identifiers

PMID21613252
PMCPMC3292426
OpenAlexW2011352206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.